These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15063915)

  • 21. A comparative evaluation of substance abuse treatment III. Examining mechanisms underlying patient-treatment matching hypotheses for 12-step and cognitive-behavioral treatments for substance abuse.
    Ouimette PC; Finney JW; Gima K; Moos RH
    Alcohol Clin Exp Res; 1999 Mar; 23(3):545-51. PubMed ID: 10195831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women-only and mixed-gender drug abuse treatment programs: service needs, utilization and outcomes.
    Niv N; Hser YI
    Drug Alcohol Depend; 2007 Mar; 87(2-3):194-201. PubMed ID: 16996232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk selection and matching in performance-based contracting.
    Lu M; Ma CT; Yuan L
    Health Econ; 2003 May; 12(5):339-54. PubMed ID: 12720252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the effectiveness of jail diversion programs for persons with serious mental illness and co-occurring substance use disorders.
    Steadman HJ; Naples M
    Behav Sci Law; 2005; 23(2):163-70. PubMed ID: 15818607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term effects of enhanced treatment for depression in primary care: results from a randomized controlled trial.
    Smit A; Kluiter H; Conradi HJ; van der Meer K; Tiemens BG; Jenner JA; van Os TW; Ormel J
    Psychol Med; 2006 Jan; 36(1):15-26. PubMed ID: 16356293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes.
    Chi FW; Satre DD; Weisner C
    Alcohol Clin Exp Res; 2006 May; 30(5):851-9. PubMed ID: 16634854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.
    Kidorf M; Disney ER; King VL; Neufeld K; Beilenson PL; Brooner RK
    Drug Alcohol Depend; 2004 May; 74(2):115-22. PubMed ID: 15099655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General practitioners' detection and management of patients with a dual diagnosis: implications for education and training.
    Marshall KL; Deane FP
    Drug Alcohol Rev; 2004 Dec; 23(4):455-62. PubMed ID: 15763750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessment and treatment of coexisting mental illness or dual diagnosis].
    Gaillard Wasser J; Dunker Scheuner D; Gammeter R; Daeppen JB
    Rev Med Suisse; 2005 Jun; 1(26):1750-4. PubMed ID: 16117050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Client matching: a severity-treatment intensity paradigm.
    De Leon G; Melnick G; Cleland CM
    J Addict Dis; 2008; 27(3):99-113. PubMed ID: 18956532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality assurance of take-over from in-patient to out-patient care: experiences in Lower Austria].
    Frühwald S; Karner A; Seyringer ME; Skribe T; Frottier P; Entenfellner A
    Neuropsychiatr; 2010; 24(3):195-9. PubMed ID: 20926058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential therapeutics and the impaired physician: patient-treatment matching by specificity and intensity.
    McGovern MP; Angres DH; Leon S
    J Addict Dis; 1998; 17(2):93-107. PubMed ID: 9567228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between mandated community treatment and perceived barriers to care in persons with severe mental illness.
    Van Dorn RA; Elbogen EB; Redlich AD; Swanson JW; Swartz MS; Mustillo S
    Int J Law Psychiatry; 2006; 29(6):495-506. PubMed ID: 17070907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
    Buckley PF
    J Clin Psychiatry; 2006; 67 Suppl 7():5-9. PubMed ID: 16961418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outpatient vs. inpatient treatment for the chronically mentally ill with substance use disorders.
    Kofoed L
    J Addict Dis; 1993; 12(3):123-37. PubMed ID: 8251539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment.
    Saxon AJ; Malte CA; Sloan KL; Baer JS; Calsyn DA; Nichol P; Chapko MK; Kivlahan DR
    Med Care; 2006 Apr; 44(4):334-42. PubMed ID: 16565634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes.
    Greig RL; Baker A; Lewin TJ; Webster RA; Carr VJ
    Drug Alcohol Rev; 2006 May; 25(3):249-58. PubMed ID: 16753649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.